Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corbus Pharmaceuticals

8.74
-0.0900-1.02%
Post-market: 8.740.00000.00%18:49 EDT
Volume:85.54K
Turnover:746.41K
Market Cap:106.95M
PE:-2.07
High:9.14
Open:8.87
Low:8.62
Close:8.83
Loading ...
Mar 15, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Major Issues Report

8-K - Current report
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2021

Major Issues Report

8-K - Current report
Jan 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 11, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 04, 2020

Major Issues Report

8-K/A [Amend] - Current report
Nov 16, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Oct 13, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Oct 08, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Major Issues Report

8-K - Current report
Sep 25, 2020

Major Issues Report

8-K - Current report
Sep 15, 2020

Major Issues Report

8-K - Current report